There is little information on left ventricular (LV) hypertrophy (LVH) development during antihypertensive treatment. We evaluate incident LVH in a treated hypertensive cohort, the Campania Salute Network registry. We analyzed prospectively 4290 hypertensives (aged 50.3±11.1 years, 40% women) with at least 1-year follow-up, without LVH at baseline. Incident LVH was defined as the first detection of echocardiographic LV mass index ≥47 in women or ≥50 g/m2.7 in men. During a median 48-month follow-up, 915 patients (21.3%) developed LVH. They were older, more frequently women, and obese (P<0.0001), with initial higher fasting glucose, diastolic and systolic blood pressure, LV mass index, lower heart rate and glomerular filtration rate, longer hypertension history and follow-up, and higher average systolic blood pressure during follow-up (all P<0.05), despite a more frequent treatment with Ca++-channel blockers and diuretics (both P<0.02). At multivariable Cox regression, incident LVH was independently associated with older age, female sex, obesity, higher average systolic blood pressure during follow-up, and initial greater LV mass index (all P<0.02). By categorizing patients according to obesity and sex, obesity independently increased the risk for incident LVH in both sexes (obese versus nonobese men: hazard ratio, 1.34; confidence interval, 1.05-1.72; P=0.019; and obese versus nonobese women: hazard ratio, 1.34; confidence interval, 1.08-1.66; P=0.007). Despite more aggressive antihypertensive therapy, 21% of hypertensive patients develop clear-cut LVH. After adjusting for confounders, risk of incident LVH is particular relevant among women and is further increased by the presence of obesity.

Development of LV hypertrophy in treated hypertensive patients: the Campania-Salute Network (CSN) / Izzo, Raffaele; Losi, MARIA ANGELA; Stabile, Eugenio; Tone Lönnebakken, Mai; Canciello, Grazia; Esposito, Giovanni; Barbato, Emanuele; DE LUCA, Nicola; Trimarco, Bruno; DE SIMONE, Giovanni. - 35:(2014), pp. 197-198. (Intervento presentato al convegno Congress of the European-Society-of-Cardiology (ESC)35 tenutosi a Barcelona, SPAIN nel AUG 30-SEP 03, 2014).

Development of LV hypertrophy in treated hypertensive patients: the Campania-Salute Network (CSN)

Raffaele Izzo;Maria-Angela Losi;Eugenio Stabile;Grazia Canciello;Giovanni Esposito;Emanuele Barbato;Nicola De Luca;Bruno Trimarco;Giovanni de Simone
2014

Abstract

There is little information on left ventricular (LV) hypertrophy (LVH) development during antihypertensive treatment. We evaluate incident LVH in a treated hypertensive cohort, the Campania Salute Network registry. We analyzed prospectively 4290 hypertensives (aged 50.3±11.1 years, 40% women) with at least 1-year follow-up, without LVH at baseline. Incident LVH was defined as the first detection of echocardiographic LV mass index ≥47 in women or ≥50 g/m2.7 in men. During a median 48-month follow-up, 915 patients (21.3%) developed LVH. They were older, more frequently women, and obese (P<0.0001), with initial higher fasting glucose, diastolic and systolic blood pressure, LV mass index, lower heart rate and glomerular filtration rate, longer hypertension history and follow-up, and higher average systolic blood pressure during follow-up (all P<0.05), despite a more frequent treatment with Ca++-channel blockers and diuretics (both P<0.02). At multivariable Cox regression, incident LVH was independently associated with older age, female sex, obesity, higher average systolic blood pressure during follow-up, and initial greater LV mass index (all P<0.02). By categorizing patients according to obesity and sex, obesity independently increased the risk for incident LVH in both sexes (obese versus nonobese men: hazard ratio, 1.34; confidence interval, 1.05-1.72; P=0.019; and obese versus nonobese women: hazard ratio, 1.34; confidence interval, 1.08-1.66; P=0.007). Despite more aggressive antihypertensive therapy, 21% of hypertensive patients develop clear-cut LVH. After adjusting for confounders, risk of incident LVH is particular relevant among women and is further increased by the presence of obesity.
2014
Development of LV hypertrophy in treated hypertensive patients: the Campania-Salute Network (CSN) / Izzo, Raffaele; Losi, MARIA ANGELA; Stabile, Eugenio; Tone Lönnebakken, Mai; Canciello, Grazia; Esposito, Giovanni; Barbato, Emanuele; DE LUCA, Nicola; Trimarco, Bruno; DE SIMONE, Giovanni. - 35:(2014), pp. 197-198. (Intervento presentato al convegno Congress of the European-Society-of-Cardiology (ESC)35 tenutosi a Barcelona, SPAIN nel AUG 30-SEP 03, 2014).
File in questo prodotto:
File Dimensione Formato  
Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: Dominio pubblico
Dimensione 565.89 kB
Formato Adobe PDF
565.89 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/626869
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact